When the expression of transcription factors was assessed, we observed that TFAP2A, TFAP2C, and GATA2 were upregulated in iMSCs compared to AD-MSCs and BM-MSCs (Supplementary Fig. 8E). The gene discussed is TFAP2C; the disease is Alzheimer disease.